Manufacturing Plants


Manufacturing is the backbone of our supply chain. We continuously strive for excellence in infrastructure and technology.

The Group has Finished Dosage and API manufacturing facilities including 2 dedicated for Oncology. All the facilities have requisite manufacturing capabilities to support our endeavour to provide quality products at competitive prices meeting the continuously increasing GMP requirements. The consistent and continued investments in the facilities have backed us to meet the customers' dynamic demands. Our sustainable focus on quality, safety and the most recent GMP and regulatory requirements have made us as one of the preferred suppliers worldwide.

Our manufacturing infrastructure* and leased manufacturing locations are regulatory approved by international agencies namely FDA-USA, MCA-UK, MCC-South Africa, TGA- Australia, ANVISA-Brazil, WHO, MFDS-Korea, EU-GMP/CEP, TPD-Canada, COFEPRIS- Mexico and PMDA-Japan.

* Reva holds JV with SML.

API - Plant-I (Oncology)

Plot No. 4A,
Deosugur Industrial Area,
Deosugur, Shaktinagar – 584 170,
Karnataka, India.

API - Plant-II (Contract Manufacturing & Oncology)

Plot No. 33, 33A & 40-47,
Raichur Industrial Growth Centre,
Wadloor Road, Raichur,
Karnataka, India.

Dosage Form - Plant-III (Formulation)

Plot No: S20 to S24A,
Green Industrial Park,
Jadcherla (M), Mahaboobnagar,
Andhra Pradesh, India.

Dosage Form - Plant-IV (Orally Disintegrating Films)

Plot No. 118, IDA, Phase - 3,
Cherlapally,
Hydrabad - 500 051,
Andhra Pradesh, India.